Avadel Pharmaceuticals Receives Orphan Drug Designation for LUMRYZ in IH

On Thursday, Avadel Pharmaceuticals (NASDAQ:AVDL) announced that its drug LUMRYZ (sodium oxybate) for extended-release oral suspension has been granted Orphan Drug Designation...

Keep Reading →